To regulate human cadaveric islets for transplantation as organs

Progress

Timeline

• Mar 19Referred to the House Committee on Energy and Commerce.

Summary

**What it does:** This bill would change how human pancreatic islets from deceased donors are regulated for transplant purposes. Currently, these islets (clusters of cells that produce insulin) are treated as biological products. The bill would reclassify them as organs instead. **Who it affects:** - People with Type 1 diabetes who might need islet transplants - Organ procurement organizations and transplant centers - Medical researchers working on diabetes treatments - Regulatory agencies overseeing transplants **What would change:** Islet transplants would follow the same regulatory pathway as other organ transplants rather than the more complex process for biological products. This could potentially: - Streamline the approval process for islet transplantation - Make this diabetes treatment more accessible to patients - Align islet regulation with how other transplant organs are handled The bill is currently under review in congressional committee.

How This Affects You